These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20093557)

  • 21. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
    Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
    Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying serum biomarkers for ovarian cancer by screening with surface-enhanced laser desorption/ionization mass spectrometry and the artificial neural network.
    Yang J; Zhu Y; Guo H; Wang X; Gao R; Zhang L; Zhao Y; Zhang X
    Int J Gynecol Cancer; 2013 May; 23(4):667-72. PubMed ID: 23574802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application Value of Mass Spectrometry in the Differentiation of Benign and Malignant Liver Tumors.
    Li B; Li B; Guo T; Sun Z; Li X; Li X; Wang H; Chen W; Chen P; Qiao M; Xia L; Mao Y
    Med Sci Monit; 2017 Apr; 23():1636-1644. PubMed ID: 28376075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of ovarian tumor classification by improved reproducibility in matrix-assisted laser desorption/ionization time-of-flight mass spectrometry of serum glycans.
    Park CW; Jo Y; Jo EJ
    Anal Biochem; 2013 Dec; 443(1):58-65. PubMed ID: 23969014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
    Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
    Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarker discovery for ovarian cancer using SELDI-TOF-MS.
    Zhang H; Kong B; Qu X; Jia L; Deng B; Yang Q
    Gynecol Oncol; 2006 Jul; 102(1):61-6. PubMed ID: 16403569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of Epithelial Ovarian Cancer using C8Magnetic Bead Separation and MALDI-TOF Plasma Proteome Profiling in Egyptian Females.
    Rizk MM; Sharaki OA; Meleis ME; Younan DN; Elkial AA; Moez P
    Asian Pac J Cancer Prev; 2019 Dec; 20(12):3603-3609. PubMed ID: 31870100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of candidate biomarkers using the Experion™ automated electrophoresis system in serum samples from ovarian cancer patients.
    Kim JH; Kim YW; Kim IW; Park DC; Kim YW; Lee KH; Jang CK; Ahn WS
    Int J Oncol; 2013 Apr; 42(4):1257-62. PubMed ID: 23443953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantification of fragments of human serum inter-alpha-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay.
    Song J; Patel M; Rosenzweig CN; Chan-Li Y; Sokoll LJ; Fung ET; Choi-Miura NH; Goggins M; Chan DW; Zhang Z
    Clin Chem; 2006 Jun; 52(6):1045-53. PubMed ID: 16574760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation of early and advanced stages in ovarian cancer using human plasma by differential scanning calorimetry and mass spectrometry.
    Kim NA; Jin JH; Kim KH; Lim DG; Cheong H; Kim YH; Ju W; Kim SC; Jeong SH
    Arch Pharm Res; 2016 May; 39(5):668-76. PubMed ID: 27002828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology].
    Wang Q; Li L; Li DR; Zhang W; Wei X; Zhang JQ; Tang Y
    Zhonghua Fu Chan Ke Za Zhi; 2006 Aug; 41(8):544-8. PubMed ID: 17083841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-resolution serum proteomic features for ovarian cancer detection.
    Conrads TP; Fusaro VA; Ross S; Johann D; Rajapakse V; Hitt BA; Steinberg SM; Kohn EC; Fishman DA; Whitely G; Barrett JC; Liotta LA; Petricoin EF; Veenstra TD
    Endocr Relat Cancer; 2004 Jun; 11(2):163-78. PubMed ID: 15163296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SELDI-TOF MS profiling of plasma proteins in ovarian cancer.
    Wu SP; Lin YW; Lai HC; Chu TY; Kuo YL; Liu HS
    Taiwan J Obstet Gynecol; 2006 Mar; 45(1):26-32. PubMed ID: 17272204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
    Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP
    J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of serum protein profiling by systematic assessment using solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry.
    Callesen AK; Christensen Rd; Madsen JS; Vach W; Zapico E; Cold S; Jørgensen PE; Mogensen O; Kruse TA; Jensen ON
    Rapid Commun Mass Spectrom; 2008; 22(3):291-300. PubMed ID: 18181248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in diagnosis of ovarian cancer: a systematic review and meta-analysis.
    Li K; Pei Y; Wu Y; Guo Y; Cui W
    J Ovarian Res; 2020 Jan; 13(1):6. PubMed ID: 31924227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors.
    Gianazza E; Chinello C; Mainini V; Cazzaniga M; Squeo V; Albo G; Signorini S; Di Pierro SS; Ferrero S; Nicolardi S; van der Burgt YE; Deelder AM; Magni F
    J Proteomics; 2012 Dec; 76 Spec No.():125-40. PubMed ID: 22868251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum proteome profiling for ovarion cancer diagnosis using ClinProt magnetic bead technique and MALDI-TOF-mass-spectrometry].
    Ziganshin RKh; Alekseev DG; Arapidi GP; Ivanov VT; Moshkovskiĭ SA; Govorun VM
    Biomed Khim; 2008; 54(4):408-19. PubMed ID: 18988457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New serum biomarkers for detection of esophageal carcinoma using Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Guo R; Pan C; Shen J; Liu C
    J Cancer Res Clin Oncol; 2011 Mar; 137(3):513-9. PubMed ID: 20490864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass spectrometric screening of ovarian cancer with serum glycans.
    Kim JH; Park CW; Um D; Baek KH; Jo Y; An H; Kim Y; Kim TJ
    Dis Markers; 2014; 2014():634289. PubMed ID: 24648610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.